Biochemical Control after external Radiotherapy (70/74 Gy) or Brachytherapy Seeds: Comparison in 1809 Patients with Prostate cancer

被引：0
|
作者：
Goldner, G. [1 ]
Poetter, R. [1 ]
Battermann, J. [2 ]
Schmid, M. P. [1 ]
Kirisits, C. [1 ]
Sljivic, S. [1 ]
van Vulpen, M. [2 ]
机构：
[1] Med Univ Wien, Univ Klin Strahlentherapie, Vienna, Austria
[2] Med Univ Utrecht, Klin Radioonkol, Utrecht, Netherlands
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2013年 / 189卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [1] Primary Radiotherapy of the "intermediate risk" - Prostate Cancer: Comparison between Seeds Brachytherapy and external Radiation therapy (70 or 74 Gy) in 890 Patients
    Goldner, G.
    Poetter, R.
    Battermann, J.
    Schmid, M. P.
    Sljivic, S.
    Kirisits, C.
    van Vulpen, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 59 - 59
  • [2] Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients
    Goldner, G.
    Poetter, R.
    Battermann, J. J.
    Schmid, M. P.
    Kirisits, C.
    Sljivic, S.
    van Vulpen, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (04) : 305 - 310
  • [3] Comparison between seeds brachytherapy and external radiation (70 or 74 Gy) in 919 Low-Risk Prostate cancer patients
    Goldner, G.
    Poetter, R.
    Battermann, J.
    Schmid, M. P.
    Sljivic, S.
    Kirisits, C.
    van Vulpen, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 37 - 37
  • [4] Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients
    Goldner, Gregor
    Poetter, Richard
    Battermann, Jan J.
    Kirisits, Christian
    Schmid, Maximilian P.
    Sljivic, Samir
    van Vulpen, Marco
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 223 - 227
  • [5] Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patientsVergleich von Seeds-Brachytherapie und externer Strahlentherapie (70 bzw. 74 Gy) bei 919 Niedrigrisiko-Prostatakarzinompatienten
    G. Goldner
    R. Pötter
    J.J. Battermann
    M.P. Schmid
    C. Kirisits
    S. Sljivic
    M. van Vulpen
    Strahlentherapie und Onkologie, 2012, 188 (4) : 305 - 310
  • [6] Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer
    Dolezel, Martin
    Odrazka, Karel
    Zouhar, Milan
    Vaculikova, Miloslava
    Sefrova, Jana
    Jansa, Jan
    Paluska, Petr
    Kohlova, Tereza
    Vanasek, Jaroslav
    Kovarik, Josef
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (04) : 338 - 346
  • [7] Salvage brachytherapy for prostate cancer biochemical recurrence after radiotherapy
    Polo Rubio, Alfredo
    Henriquez Lopez, Ivan J.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2012, 65 (01): : 145 - 157
  • [8] Biochemical relapse free survival rates after hypofractionated external beam radiotherapy (70 Gy at 2.5 Gy per fraction) versus standard fractionation radiotherapy (78 Gy at 2.0 Gy per fraction) for localized prostate cancer
    Quan, AL
    Reddy, CA
    Willoughby, TR
    Kupelian, PA
    RADIOLOGY, 2002, 225 : 319 - 319
  • [9] Analysis of the Cancer of the Prostate Risk Assessment to Predict for Biochemical Failure After External Beam Radiotherapy or Prostate Seed Brachytherapy
    Delouya, Guila
    Krishnan, Vimal
    Bahary, Jean-Paul
    Larrivee, Sandra
    Taussky, Daniel
    UROLOGY, 2014, 84 (03) : 629 - 633
  • [10] Dosimetric predictors of biochemical control of prostate cancer in patients randomised to external beam radiotherapy with a boost of high dose rate brachytherapy
    Hoskin, Peter J.
    Rojas, Ana M.
    Ostler, Peter J.
    Hughes, Robert
    Bryant, Linda
    Lowe, Gerry J.
    RADIOTHERAPY AND ONCOLOGY, 2014, 110 (01) : 110 - 113
12345